Building on this understanding, we postulated that HMOX1 expression within a comprehensive tumor gene expression data set could serve as a marker for investigating the influence of microhemorrhage on the development of CD163+ and SPP1+ TAMs, which are implicated in tumor progression. Here, CD163 is linked to neoplasm.